Mutant GABAA receptor subunits in genetic (idiopathic) epilepsy

Progress in Brain Research

Volumn 213, Issue C, 2014, Pages 55-85

  Hirose, Shinichi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Channelopathy; Convulsions; Endoplasmic reticulum associated degradation; ER stress; GABA; Nonsense mediated mRNA decay; Severe myoclonic epilepsy in infancy; Ubiquitin

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA6; 4 AMINOBUTYRIC ACID A RECEPTOR BETA2; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHILDHOOD ABSENCE EPILEPSY; ENDOPLASMIC RETICULUM; FEBRILE CONVULSION; GENE MUTATION; GENERALIZED EPILEPSY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; MYOCLONUS EPILEPSY; NONSENSE MEDIATED MRNA DECAY; PRIORITY JOURNAL; SEVERE MYOCLONIC EPILEPSY IN INFANCY; ANIMAL; GENETICS; MUTATION;

ANIMALS; EPILEPSY, GENERALIZED; HUMANS; MUTATION; RECEPTORS, GABA-A;

EID: 84926337190     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-63326-2.00003-X     Document Type: Chapter

References (122)

1. Allen A.S., Berkovic S.F., Cossette P., Delanty N., Dlugos D., Eichler E.E., Epstein M.P., Glauser T., Goldstein D.B., Han Y., Heinzen E.L., Hitomi Y., Howell K.B., Johnson M.R., Kuzniecky R., Lowenstein D.H., Lu Y.F., Madou M.R., Marson A.G., Mefford H.C., Esmaeeli Nieh S., O'Brien T.J., Ottman R., Petrovski S., Poduri A., Ruzzo E.K., Scheffer I.E., Sherr E.H., Yuskaitis C.J., Abou-Khalil B., Alldredge B.K., Bautista J.F., Boro A., Cascino G.D., Consalvo D., Crumrine P., Devinsky O., Fiol M., Fountain N.B., French J., Friedman D., Geller E.B., Glynn S., Haut S.R., Hayward J., Helmers S.L., Joshi S., Kanner A., Kirsch H.E., Knowlton R.C., Kossoff E.H., Kuperman R., Mcguire S.M., Motika P.V., Novotny E.J., Paolicchi J.M., Parent J.M., Park K., Shellhaas R.A., Shih J.J., Singh R., Sirven J., Smith M.C., Sullivan J., Lin Thio L., Venkat A., Vining E.P., Von Allmen G.K., Weisenberg J.L., Widdess-Walsh P., Winawer M.R. De novo mutations in epileptic encephalopathies. Nature 2013, 501:217-221.
2. A receptor alpha1 subunit. Epilepsia 2012, 53:e161-e165.
3. Audenaert D., Schwartz E., Claeys K.G., Claes L., Deprez L., Suls A., Van Dyck T., Lagae L., Van Broeckhoven C., MacDonald R.L., De Jonghe P. A novel GABRG2 mutation associated with febrile seizures. Neurology 2006, 67:687-690.
4. Bai D., Zhu G., Pennefather P., Jackson M.F., MacDonald J.F., Orser B.A. Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by gamma-aminobutyric acid(A) receptors in hippocampal neurons. Mol. Pharmacol. 2001, 59:814-824.
5. Baulac S., Huberfeld G., Gourfinkel-An I., Mitropoulou G., Beranger A., Prud'Homme J.F., Baulac M., Brice A., Bruzzone R., Leguern E. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene. Nat. Genet. 2001, 28:46-48.
6. A receptors Insight into the absolute arrangement. J. Biol. Chem. 2002, 277:46020-46025.
7. Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., Cross J.H., Van Emde Boas W., Engel J., French J., Glauser T.A., Mathern G.W., Moshe S.L., Nordli D., Plouin P., Scheffer I.E. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 51:676-685.
8. A receptor mutations linked to epilepsy in humans. J. Neurosci. 2002, 22:5321-5327.
9. A receptors. Cereb. Cortex 2012, 22:1542-1553.
10. A receptor subunit mutation [γ2(R43Q)] found in human epilepsy. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15170-15175.
11. Brooks-Kayal A.R., Pritchett D.B. Developmental changes in human gamma-aminobutyric acid A receptor subunit composition. Ann. Neurol. 1993, 34:687-693.
12. Carvill G.L., Heavin S.B., Yendle S.C., Mcmahon J.M., O'Roak B.J., Cook J., Khan A., Dorschner M.O., Weaver M., Calvert S., Malone S., Wallace G., Stanley T., Bye A.M., Bleasel A., Howell K.B., Kivity S., Mackay M.T., Rodriguez-Casero V., Webster R., Korczyn A., Afawi Z., Zelnick N., Lerman-Sagie T., Lev D., Moller R.S., Gill D., Andrade D.M., Freeman J.L., Sadleir L.G., Shendure J., Berkovic S.F., Scheffer I.E., Mefford H.C. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat. Genet. 2013, 45:825-830.
13. Chandra D., Korpi E.R., Miralles C.P., De Blas A.L., Homanics G.E. GABAA receptor gamma 2 subunit knockdown mice have enhanced anxiety-like behavior but unaltered hypnotic response to benzodiazepines. BMC Neurosci. 2005, 6:30.
14. A) receptors revealed by a γ2(R43Q) epilepsy mutation. J. Biol. Chem. 2013, 288:28254-28265.
15. Chen C., Westenbroek R.E., Xu X., Edwards C.A., Sorenson D.R., Chen Y., Mcewen D.P., O'Malley H.A., Bharucha V., Meadows L.S., Knudsen G.A., Vilaythong A., Noebels J.L., Saunders T.L., Scheuer T., Shrager P., Catterall W.A., Isom L.L. Mice lacking sodium channel β1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J. Neurosci. 2004, 24:4030-4042.
16. A receptor epilepsy mutation. Ann. Neurol. 2008, 64:284-293.
17. Cook E.H., Lindgren V., Leventhal B.L., Courchesne R., Lincoln A., Shulman C., Lord C., Courchesne E. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet. 1997, 60:928-934.
18. A inhibition in typical absence epilepsy. Nat. Med. 2009, 15:1392-1398.
19. Cossette P., Liu L., Brisebois K., Dong H., Lortie A., Vanasse M., Saint-Hilaire J.M., Carmant L., Verner A., Lu W.Y., Wang Y.T., Rouleau G.A. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat. Genet. 2002, 31:184-189.
20. A receptor subunits in idiopathic generalized epilepsy. Jasper's Basic Mechanisms of the Epilepsies 2012, U.S. National Center for Biotechnology Information, Bethesda, MD. fourth ed. J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (Eds.).
21. A-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat. Neurosci. 1999, 2:833-839.
22. Delahanty R.J., Kang J.Q., Brune C.W., Kistner E.O., Courchesne E., Cox N.J., Cook E.H., Macdonald R.L., Sutcliffe J.S. Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism. Mol. Psychiatry 2011, 16:86-96.
23. Delorey T.M., Olsen R.W. GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man. Epilepsy Res. 1999, 36:123-132.
24. A receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J. Neurosci. 1998, 18:8505-8514.
25. Den Dunnen J.T., Antonarakis S.E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum. Mutat. 2000, 15:7-12.
26. A receptors is a susceptibility locus for generalized epilepsies. Hum. Mol. Genet. 2004, 13:1315-1319.
27. Dibbens L.M., Harkin L.A., Richards M., Hodgson B.L., Clarke A.L., Petrou S., Scheffer I.E., Berkovic S.F., Mulley J.C. The role of neuronal GABA(A) receptor subunit mutations in idiopathic generalized epilepsies. Neurosci. Lett. 2009, 453:162-165.
28. Ding L., Feng H.J., Macdonald R.L., Botzolakis E.J., Hu N., Gallagher M.J. GABA(A) receptor alpha1 subunit mutation A322D associated with autosomal dominant juvenile myoclonic epilepsy reduces the expression and alters the composition of wild type GABA(A) receptors. J. Biol. Chem. 2010, 285:26390-26405.
29. Dzhala V.I., Talos D.M., Sdrulla D.A., Brumback A.C., Mathews G.C., Benke T.A., Delpire E., Jensen F.E., Staley K.J. NKCC1 transporter facilitates seizures in the developing brain. Nat. Med. 2005, 11:1205-1213.
30. A receptor subtypes requires the gamma 2 subunit and gephyrin. Nat. Neurosci. 1998, 1:563-571.
31. Eugene E., Depienne C., Baulac S., Baulac M., Fritschy J.M., Le Guern E., Miles R., Poncer J.C. GABA(A) receptor γ2 subunit mutations linked to human epileptic syndromes differentially affect phasic and tonic inhibition. J. Neurosci. 2007, 27:14108-14116.
32. Fang C., Deng L., Keller C.A., Fukata M., Fukata Y., Chen G., Luscher B. GODZ-mediated palmitoylation of GABA(A) receptors is required for normal assembly and function of GABAergic inhibitory synapses. J. Neurosci. 2006, 26:12758-12768.
33. Farrant M., Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat. Rev. Neurosci. 2005, 6:215-229.
34. A receptor mutation causing generalized epilepsy reduces benzodiazepine receptor binding. Neuroimage 2006, 32:995-1000.
35. A receptor mutation. Cereb. Cortex 2008, 18:664-669.
36. A receptors. J. Neurosci. 2006, 26:1499-1506.
37. Feucht M., Fuchs K., Pichlbauer E., Hornik K., Scharfetter J., Goessler R., Fureder T., Cvetkovic N., Sieghart W., Kasper S., Aschauer H. Possible association between childhood absence epilepsy and the gene encoding GABRB3. Biol. Psychiatry 1999, 46:997-1002.
38. A receptor assembly and modifies subunit composition on the cell surface. J. Biol. Chem. 2007, 282:3819-3828.
39. Fukuda A. Diuretic soothes seizures in newborns. Nat. Med. 2005, 11:1153-1154.
40. Gallagher M.J., Song L., Arain F., MacDonald R.L. The juvenile myoclonic epilepsy GABA(A) receptor alpha1 subunit mutation A322D produces asymmetrical, subunit position-dependent reduction of heterozygous receptor currents and alpha1 subunit protein expression. J. Neurosci. 2004, 24:5570-5578.
41. A receptor epilepsy mutation that inserts an aspartate in the M3 transmembrane segment of the alpha1 subunit. J. Biol. Chem. 2005, 280:37995-38004.
42. A receptor alpha1 subunit epilepsy mutation A322D inhibits transmembrane helix formation and causes proteasomal degradation. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12999-13004.
43. Gunther U., Benson J., Benke D., Fritschy J.M., Reyes G., Knoflach F., Crestani F., Aguzzi A., Arigoni M., Lang Y., et al. Benzodiazepine-insensitive mice generated by targeted disruption of the γ2 subunit gene of gamma-aminobutyric acid type A receptors. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7749-7753.
44. A) receptor expression and channel gating. J. Biol. Chem. 2012, 287:12083-12097.
45. A receptors. Mol. Cell. Neurosci. 2005, 29:120-127.
46. Hales T.G., Deeb T.Z., Tang H., Bollan K.A., King D.P., Johnson S.J., Connolly C.N. An asymmetric contribution to gamma-aminobutyric type A receptor function of a conserved lysine within TM2-3 of α1, β2, and γ2 subunits. J. Biol. Chem. 2006, 281:17034-17043.
47. Harkin L.A., Bowser D.N., Dibbens L.M., Singh R., Phillips F., Wallace R.H., Richards M.C., Williams D.A., Mulley J.C., Berkovic S.F., Scheffer I.E., Petrou S. Truncation of the GABA(A)-receptor γ2 subunit in a family with generalized epilepsy with febrile seizures plus. Am. J. Hum. Genet. 2002, 70:530-536.
48. Hernandez C.C., Gurba K.N., Hu N., Macdonald R.L. The GABRA6 mutation, R46W, associated with childhood absence epilepsy, alters 6β22 and 6β2 GABA(A) receptor channel gating and expression. J. Physiol. 2011, 589:5857-5878.
49. Higurashi N., Uchida T., Lossin C., Misumi Y., Okada Y., Akamatsu W., Imaizumi Y., Zhang B., Nabeshima K., Mori M.X., Katsurabayashi S., Shirasaka Y., Okano H., Hirose S. A human Dravet syndrome model from patient induced pluripotent stem cells. Mol. Brain 2013, 6:19.
50. Hill E.L., Hosie S., Mulligan R.S., Richards K.L., Davies P.J., Dube C.M., Baram T.Z., Reid C.A., Jones M.V., Petrou S. Temperature elevation increases GABA(A) -mediated cortical inhibition in a mouse model of genetic epilepsy. Epilepsia 2011, 52:179-184.
51. Hirose S. A new paradigm of channelopathy in epilepsy syndromes: intracellular trafficking abnormality of channel molecules. Epilepsy Res. 2006, 70(Suppl. 1):S206-S217.
52. Hirose S., Iwata H., Akiyoshi H., Kobayashi K., Ito M., Wada K., Kaneko S., Mitsudome A. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology 1999, 53:1749-1753.
53. Hirose S., Okada M., Kaneko S., Mitsudome A. Are some idiopathic epilepsies disorders of ion channels? A working hypothesis. Epilepsy Res. 2000, 41:191-204.
54. Hirose S., Okada M., Kaneko S., Mitsudome A. Molecular genetics of human familial epilepsy syndromes. Epilepsia 2002, 43(Suppl. 9):21-25.
55. Hirose S., Okada M., Yamakawa K., Sugawara T., Fukuma G., Ito M., Kaneko S., Mitsudome A. Genetic abnormalities underlying familial epilepsy syndromes. Brain Dev. 2002, 24:211-222.
56. Hirose S., Mohney R.P., Okada M., Kaneko S., Mitsudome A. The genetics of febrile seizures and related epilepsy syndromes. Brain Dev. 2003, 25:304-312.
57. Hirose S., Mitsudome A., Okada M., Kaneko S. Genetics of idiopathic epilepsies. Epilepsia 2005, 46(Suppl. 1):38-43.
58. Hirose S., Scheffer I.E., Marini C., De Jonghe P., Andermann E., Goldman A.M., Kauffman M., Tan N.C., Lowenstein D.H., Sisodiya S.M., Ottman R., Berkovic S.F. SCN1A testing for epilepsy: application in clinical practice. Epilepsia 2013, 54:946-952.
59. Homanics G.E., Delorey T.M., Firestone L.L., Quinlan J.J., Handforth A., Harrison N.L., Krasowski M.D., Rick C.E., Korpi E.R., Makela R., Brilliant M.H., Hagiwara N., Ferguson C., Snyder K., Olsen R.W. Mice devoid of gamma-aminobutyrate type A receptor β3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:4143-4148.
60. Huang X., Tian M., Hernandez C.C., Hu N., Macdonald R.L. The GABRG2 nonsense mutation, Q40X, associated with Dravet syndrome activated NMD and generated a truncated subunit that was partially rescued by aminoglycoside-induced stop codon read-through. Neurobiol. Dis. 2012, 48:115-123.
61. A receptors in severe epilepsy. Epilepsy Res. 2014, 108:420-432.
62. +)-channel α1 subunit gene, SCN1A. Epilepsy Res. 2002, 48:15-23.
63. Johnston A.J., Kang J.Q., Shen W., Pickrell W.O., Cushion T.D., Davies J.S., Baer K., Mullins J.G., Hammond C.L., Chung S.K., Thomas R.H., White C., Smith P.E., Macdonald R.L., Rees M.I. A novel GABRG2 mutation, p.R136*, in a family with GEFS+ and extended phenotypes. Neurobiol. Dis. 2014, 64:131-141.
64. A receptor alpha6 subunit gene inactivation inhibits delta subunit expression. J. Neurosci. 1997, 17:1350-1362.
65. Kananura C., Haug K., Sander T., Runge U., Gu W., Hallmann K., Rebstock J., Heils A., Steinlein O.K. A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch. Neurol. 2002, 59:1137-1141.
66. A receptor gamma2 subunit R43Q mutation linked to childhood absence epilepsy and febrile seizures causes retention of α1β2γ2S receptors in the endoplasmic reticulum. J. Neurosci. 2004, 24:8672-8677.
67. Kang J.Q., MacDonald R.L. Making sense of nonsense GABA(A) receptor mutations associated with genetic epilepsies. Trends Mol. Med. 2009, 15:430-438.
68. A receptor γ2 subunit mutations associated with idiopathic generalized epilepsies have temperature-dependent trafficking deficiencies. J. Neurosci. 2006, 26:2590-2597.
69. Kang J.Q., Shen W., MacDonald R.L. The GABRG2 mutation, Q351X, associated with generalized epilepsy with febrile seizures plus, has both loss of function and dominant-negative suppression. J. Neurosci. 2009, 29:2845-2856.
70. Kang J.Q., Shen W., MacDonald R.L. Two molecular pathways (NMD and ERAD) contribute to a genetic epilepsy associated with the GABA(A) receptor GABRA1 PTC mutation, 975delC, S326fs328X. J. Neurosci. 2009, 29:2833-2844.
71. Kang J.Q., Shen W., MacDonald R.L. Trafficking-deficient mutant GABRG2 subunit amount may modify epilepsy phenotype. Ann. Neurol. 2013, 74:547-559.
72. Kim Y.O., Kim M.K., Nam T.S., Jang S.Y., Park K.W., Kim E.Y., Rho Y.I., Woo Y.J. Mutation screening of the gamma-aminobutyric acid type-A receptor subunit γ2 gene in Korean patients with childhood absence epilepsy. J. Clin. Neurol. 2012, 8:271-275.
73. Kirkness E.F., Fraser C.M. A strong promoter element is located between alternative exons of a gene encoding the human gamma-aminobutyric acid-type A receptor β3 subunit (GABRB3). J. Biol. Chem. 1993, 268:4420-4428.
74. Kralic J.E., O'Buckley T.K., Khisti R.T., Hodge C.W., Homanics G.E., Morrow A.L. GABA(A) receptor α-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem. Neuropharmacology 2002, 43:685-694.
75. Kurahashi H., Hirose S. Autosomal dominant nocturnal frontal lobe epilepsy. GeneReviews 1993, University of Washington, Seattle, WA. R.A. Pagon, M.P. Adam, T.D. Bird, C.R. Dolan, C.T. Fong, R.J.H. Smith, K. Stephens (Eds.).
76. Lachance-Touchette P., Martin C., Poulin C., Gravel M., Carmant L., Cossette P. Screening of GABRB3 in French-Canadian families with idiopathic generalized epilepsy. Epilepsia 2010, 51:1894-1897.
77. A receptor subunit mutations in families with idiopathic generalized epilepsy. Eur. J. Neurosci. 2011, 34:237-249.
78. Lenzen K.P., Heils A., Lorenz S., Hempelmann A., Sander T. Association analysis of the Arg220His variation of the human gene encoding the GABA δ subunit with idiopathic generalized epilepsy. Epilepsy Res. 2005, 65:53-57.
79. Ma S., Abou-Khalil B., Blair M.A., Sutcliffe J.S., Haines J.L., Hedera P. Mutations in GABRA1, GABRA5, GABRG2 and GABRD receptor genes are not a major factor in the pathogenesis of familial focal epilepsy preceded by febrile seizures. Neurosci. Lett. 2006, 394:74-78.
80. Ma S., Blair M.A., Abou-Khalil B., Lagrange A.H., Gurnett C.A., Hedera P. Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy. Epilepsy Res. 2006, 71:129-134.
81. A receptor channels. Annu. Rev. Neurosci. 1994, 17:569-602.
82. MacDonald R.L., Bianchi M.T., Feng H. Mutations linked to generalized epilepsy in humans reduce GABA(A) receptor current. Exp. Neurol. 2003, 184(Suppl. 1):S58-S67.
83. MacDonald R.L., Gallagher M.J., Feng H.J., Kang J. GABA(A) receptor epilepsy mutations. Biochem. Pharmacol. 2004, 68:1497-1506.
84. Maljevic S., Krampfl K., Cobilanschi J., Tilgen N., Beyer S., Weber Y.G., Schlesinger F., Ursu D., Melzer W., Cossette P., Bufler J., Lerche H., Heils A. A mutation in the GABA(A) receptor α(1)-subunit is associated with absence epilepsy. Ann. Neurol. 2006, 59:983-987.
85. Malueka R.G., Yagi M., Awano H., Lee T., Dwianingsih E.K., Nishida A., Takeshima Y., Matsuo M. Antisense oligonucleotide induced dystrophin exon 45 skipping at a low half-maximal effective concentration in a cell-free splicing system. Nucleic Acid Ther. 2011, 21:347-353.
86. Marini C., Harkin L.A., Wallace R.H., Mulley J.C., Scheffer I.E., Berkovic S.F. Childhood absence epilepsy and febrile seizures: a family with a GABA(A) receptor mutation. Brain 2003, 126:230-240.
87. Matsuo M., Masumura T., Nishio H., Nakajima T., Kitoh Y., Takumi T., Koga J., Nakamura H. Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe. J. Clin. Invest. 1991, 87:2127-2131.
88. Meusser B., Hirsch C., Jarosch E., Sommer T. ERAD: the long road to destruction. Nat. Cell Biol. 2005, 7:766-772.
89. A receptor γ2 subunit mutation associated with seizures. J. Pharmacol. Sci. 2013, 121:84-87.
90. Minassian B.A., Delorey T.M., Olsen R.W., Philippart M., Bronstein Y., Zhang Q., Guerrini R., Van Ness P., Livet M.O., Delgado-Escueta A.V. Angelman syndrome: correlations between epilepsy phenotypes and genotypes. Ann. Neurol. 1998, 43:485-493.
91. Nicolazzo J.A., Steuten J.A., Charman S.A., Taylor N., Davies P.J., Petrou S. Brain uptake of diazepam and phenytoin in a genetic animal model of absence epilepsy. Clin. Exp. Pharmacol. Physiol. 2010, 37:647-649.
92. Nishida A., Kataoka N., Takeshima Y., Yagi M., Awano H., Ota M., Itoh K., Hagiwara M., Matsuo M. Chemical treatment enhances skipping of a mutated exon in the dystrophin gene. Nat. Commun. 2011, 2:308.
93. Ogiwara I., Miyamoto H., Morita N., Atapour N., Mazaki E., Inoue I., Takeuchi T., Itohara S., Yanagawa Y., Obata K., Furuichi T., Hensch T.K., Yamakawa K. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J. Neurosci. 2007, 27:5903-5914.
94. Ogiwara I., Nakayama T., Yamagata T., Ohtani H., Mazaki E., Tsuchiya S., Inoue Y., Yamakawa K. A homozygous mutation of voltage-gated sodium channel β(I) gene SCN1B in a patient with Dravet syndrome. Epilepsia 2012, 53:e200-e203.
95. v1.1 haploinsufficiency in excitatory neurons ameliorates seizure-associated sudden death in a mouse model of Dravet syndrome. Hum. Mol. Genet. 2013, 22:4784-4804.
96. Olsen R.W., Sieghart W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol. Rev. 2008, 60:243-260.
97. Patino G.A., Claes L.R., Lopez-Santiago L.F., Slat E.A., Dondeti R.S., Chen C., O'Malley H.A., Gray C.B., Miyazaki H., Nukina N., Oyama F., De Jonghe P., Isom L.L. A functional null mutation of SCN1B in a patient with Dravet syndrome. J. Neurosci. 2009, 29:10764-10778.
98. Ramakrishnan L., Hess G.P. On the mechanism of a mutated and abnormally functioning gamma-aminobutyric acid (A) receptor linked to epilepsy. Biochemistry 2004, 43:7534-7540.
99. A mutation in epilepsy. Neurology 2013, 80:1003-1008.
100. Richards K.L., Kurniawan N.D., Yang Z., Kim T.H., Keller M.D., Low J., Ullmann J.F., Cole S., Foong S., Galloway G.J., Reid C.A., Paxinos G., Reutens D.C., Petrou S. Hippocampal volume and cell density changes in a mouse model of human genetic epilepsy. Neurology 2013, 80:1240-1246.
101. A receptor mutation linked to human epilepsy (γ2R43Q) impairs cell surface expression of αβγ receptors. J. Biol. Chem. 2004, 279:47034-47039.
102. A receptor subunits: role of the delta subunit. J. Neurosci. 1994, 14:7077-7086.
103. Shi X., Yasumoto S., Nakagawa E., Fukasawa T., Uchiya S., Hirose S. Missense mutation of the sodium channel gene SCN2A causes Dravet syndrome. Brain Dev. 2009, 31:758-762.
104. Shi X., Huang M.C., Ishii A., Yoshida S., Okada M., Morita K., Nagafuji H., Yasumoto S., Kaneko S., Kojima T., Hirose S. Mutational analysis of GABRG2 in a Japanese cohort with childhood epilepsies. J. Hum. Genet. 2010, 55:375-378.
105. Shi X., Yasumoto S., Kurahashi H., Nakagawa E., Fukasawa T., Uchiya S., Hirose S. Clinical spectrum of SCN2A mutations. Brain Dev. 2012, 34:541-545.
106. Sieghart W., Sperk G. Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr. Top. Med. Chem. 2002, 2:795-816.
107. A receptors. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:14439-14444.
108. Sun H., Zhang Y., Liang J., Liu X., Ma X., Wu H., Xu K., Qin J., Qi Y., Wu X. SCN1A, SCN1B, and GABRG2 gene mutation analysis in Chinese families with generalized epilepsy with febrile seizures plus. J. Hum. Genet. 2008, 53:769-774.
109. Tan H.O., Reid C.A., Single F.N., Davies P.J., Chiu C., Murphy S., Clarke A.L., Dibbens L., Krestel H., Mulley J.C., Jones M.V., Seeburg P.H., Sakmann B., Berkovic S.F., Sprengel R., Petrou S. Reduced cortical inhibition in a mouse model of familial childhood absence epilepsy. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17536-17541.
110. Tanaka M., Olsen R.W., Medina M.T., Schwartz E., Alonso M.E., Duron R.M., Castro-Ortega R., Martinez-Juarez I.E., Pascual-Castroviejo I., Machado-Salas J., Silva R., Bailey J.N., Bai D., Ochoa A., Jara-Prado A., Pineda G., Macdonald R.L., Delgado-Escueta A.V. Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy. Am. J. Hum. Genet. 2008, 82:1249-1261.
111. Tian M., MacDonald R.L. The intronic GABRG2 mutation, IVS6+2T->G, associated with childhood absence epilepsy altered subunit mRNA intron splicing, activated nonsense-mediated decay, and produced a stable truncated γ2 subunit. J. Neurosci. 2012, 32:5937-5952.
112. Tian M., Mei D., Freri E., Hernandez C.C., Granata T., Shen W., MacDonald R.L., Guerrini R. Impaired surface alphabetagamma GABA(A) receptor expression in familial epilepsy due to a GABRG2 frameshift mutation. Neurobiol. Dis. 2013, 50:135-141.
113. Urak L., Feucht M., Fathi N., Hornik K., Fuchs K. A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity. Hum. Mol. Genet. 2006, 15:2533-2541.
114. Vargas E., Petrou S., Reid C.A. Genetic and pharmacological modulation of giant depolarizing potentials in the neonatal hippocampus associates with increased seizure susceptibility. J. Physiol. 2013, 591:57-65.
115. Vicini S., Ferguson C., Prybylowski K., Kralic J., Morrow A.L., Homanics G.E. GABA(A) receptor alpha1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons. J. Neurosci. 2001, 21:3009-3016.
116. Wallace R.H., Marini C., Petrou S., Harkin L.A., Bowser D.N., Panchal R.G., Williams D.A., Sutherland G.R., Mulley J.C., Scheffer I.E., Berkovic S.F. Mutant GABA(A) receptor γ2-subunit in childhood absence epilepsy and febrile seizures. Nat. Genet. 2001, 28:49-52.
117. Wei W., Zhang N., Peng Z., Houser C.R., Mody I. Perisynaptic localization of delta subunit-containing GABA(A) receptors and their activation by GABA spillover in the mouse dentate gyrus. J. Neurosci. 2003, 23:10650-10661.
118. Welch E.M., Barton E.R., Zhuo J., Tomizawa Y., Friesen W.J., Trifillis P., Paushkin S., Patel M., Trotta C.R., Hwang S., Wilde R.G., Karp G., Takasugi J., Chen G., Jones S., Ren H., Moon Y.C., Corson D., Turpoff A.A., Campbell J.A., Conn M.M., Khan A., Almstead N.G., Hedrick J., Mollin A., Risher N., Weetall M., Yeh S., Branstrom A.A., Colacino J.M., Babiak J., Ju W.D., Hirawat S., Northcutt V.J., Miller L.L., Spatrick P., He F., Kawana M., Feng H., Jacobson A., Peltz S.W., Sweeney H.L. PTC124 targets genetic disorders caused by nonsense mutations. Nature 2007, 447:87-91.
119. Whiting P.J. GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?. Drug Discov. Today 2003, 8:445-450.
120. Xiumin W., Meichun X., Lizhong D. Association analysis of γ2 subunit of gamma-aminobutyric acid (GABA) type A receptor and voltage-gated sodium channel type II α-polypeptide gene mutation in southern Chinese children with febrile seizures. J. Child Neurol. 2007, 22:714-719.
121. Yamada J., Zhu G., Okada M., Hirose S., Yoshida S., Shiba Y., Migita K., Mori F., Sugawara T., Chen L., Liu F., Ueno S., Kaneko S. A novel prophylactic effect of furosemide treatment on autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). Epilepsy Res. 2013, 107:127-137.
122. Zhu G., Okada M., Yoshida S., Ueno S., Mori F., Takahara T., Saito R., Miura Y., Kishi A., Tomiyama M., Sato A., Kojima T., Fukuma G., Wakabayashi K., Hase K., Ohno H., Kijima H., Takano Y., Mitsudome A., Kaneko S., Hirose S. Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype. J. Neurosci. 2008, 28:12465-12476.